17-(3-pyridyl)androsta-5,16-dien-3-one has been researched along with Androgen-Independent Prostatic Cancer in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 3 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Arasaratnam, M; Bhatnagar, A; Crumbaker, M; Gurney, H; McKay, MJ; Molloy, MP; Thaysen-Andersen, M | 1 |
| Ahire, K; Bhatnagar, A; Crumbaker, M; Gurney, H; Karuso, P; McKay, MJ; Molloy, MP | 1 |
| Alyamani, M; Auchus, RJ; Bishop, AC; Bunch, D; Dreicer, R; Garcia, JA; Li, Z; Liu, J; Sharifi, N; Upadhyay, SK | 1 |
3 other study(ies) available for 17-(3-pyridyl)androsta-5,16-dien-3-one and Androgen-Independent Prostatic Cancer
| Article | Year |
|---|---|
Bioanalytical evaluation of dried plasma spots for monitoring of abiraterone and ∆(4)-abiraterone from cancer patients.
Topics: Androstenes; Chromatography, Liquid; Dried Blood Spot Testing; Drug Monitoring; Humans; Linear Models; Male; Prostatic Neoplasms, Castration-Resistant; Reproducibility of Results; Sensitivity and Specificity; Tandem Mass Spectrometry | 2019 |
Quantitation of the anticancer drug abiraterone and its metabolite Δ(4)-abiraterone in human plasma using high-resolution mass spectrometry.
Topics: Androgen Receptor Antagonists; Androstenes; Antineoplastic Agents; Biological Variation, Population; Chromatography, High Pressure Liquid; Humans; Male; Prodrugs; Prostatic Neoplasms, Castration-Resistant; Sensitivity and Specificity; Steroid 17-alpha-Hydroxylase; Tandem Mass Spectrometry | 2018 |
Conversion of abiraterone to D4A drives anti-tumour activity in prostate cancer.
Topics: 3-Hydroxysteroid Dehydrogenases; 3-Oxo-5-alpha-Steroid 4-Dehydrogenase; 5-alpha Reductase Inhibitors; Androgen Receptor Antagonists; Androgens; Androstenes; Animals; Benzamides; Biosynthetic Pathways; Biotransformation; Cell Division; Chromatin; Dihydrotestosterone; Gene Expression Regulation, Neoplastic; Humans; Male; Mice; Nitriles; Phenylthiohydantoin; Prostatic Neoplasms; Prostatic Neoplasms, Castration-Resistant; Receptors, Androgen; Steroid 17-alpha-Hydroxylase; Survival Analysis; Xenograft Model Antitumor Assays | 2015 |